Treatment of Oculopharyngeal Muscular Dystrophy With Trehalose
Clinical trial NCT04226924 · WITHDRAWN
Trial details
- NCT number
- NCT04226924
- Sponsor
- Bioblast Pharma Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-15
- Primary completion
- 2018-02-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.